BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2 AND Treatment
22 results:

  • 1. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal cancer Cell Lines Regardless of HPV Status.
    Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
    Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease treatment.
    Olloquequi J; Ettcheto M; Cano A; Fortuna A; Bicker J; Sánchez-Lopez E; Paz C; Ureña J; Verdaguer E; Auladell C; Camins A
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762479
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Erdafitinib in the treatment of Metastatic Urothelial Carcinoma.
    Castro-Alonso FJ; Beas-Lozano E; Remolina-Bonilla YA; Flaig TW; Bourlon MT
    Oncology (Williston Park); 2023 Jun; 37(6):256-261. PubMed ID: 37343207
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
    Kovács SA; Fekete JT; Győrffy B
    Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Bilateral parotid glands aplasia: a case report and literature review.
    Kuralt H; Fidler A; Blatnik A; Novaković S; Plavc G
    Oral Radiol; 2022 Jul; 38(3):423-429. PubMed ID: 35076829
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 Aptamer.
    Nakamura Y
    Cells; 2021 Jun; 10(7):. PubMed ID: 34203430
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A brief guide to pustular psoriasis for primary care providers.
    Crowley JJ; Pariser DM; Yamauchi PS
    Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Topical rapamycin for acanthosis nigricans in the Fitzpatrick IV/V adolescent population.
    Coerdt KM; Todd SP; DeKlotz CMC
    Pediatr Dermatol; 2021 Jan; 38(1):296-298. PubMed ID: 33099783
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The molecular pathogenesis of Trichilemmal carcinoma.
    Ha JH; Lee C; Lee KS; Pak CS; Sun CH; Koh Y; Chang H
    BMC Cancer; 2020 Jun; 20(1):516. PubMed ID: 32493317
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Personalized and targeted mutational analysis of multiple second primary melanomas under kinase inhibitors.
    Donati M; Zelano G; Coppola R; Cinelli E; Verri M; Persichetti P; Perrella E; Devirgiliis V; Calvieri S; Crescenzi A; Panasiti V
    Ital J Dermatol Venerol; 2021 Oct; 156(5):593-598. PubMed ID: 31804055
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy.
    Jacob JM; Ferry EK; Gay LM; Elvin JA; Vergilio JA; Ramkissoon S; Severson E; Necchi A; Killian JK; Ali SM; Schrock AB; Liu NW; Chung J; Miller VA; Stephens PJ; Welsh A; Corona RJ; Ross JS; Bratslavsky G
    J Urol; 2019 Mar; 201(3):541-548. PubMed ID: 30291913
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
    Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
    BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mutational Analysis of BRAF Inhibitor-Associated Squamoproliferative Lesions.
    Clynick B; Tabone T; Fuller K; Erber W; Meehan K; Millward M; Wood BA; Harvey NT
    J Mol Diagn; 2015 Nov; 17(6):644-51. PubMed ID: 26319365
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Transcriptional regulation of SLURP2, a psoriasis-associated gene, is under control of IL-22 in the skin: A special reference to the nested gene LYNX1.
    Moriwaki Y; Takada K; Tsuji S; Kawashima K; Misawa H
    Int Immunopharmacol; 2015 Nov; 29(1):71-5. PubMed ID: 26033490
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (fgfr3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma.
    Yadav V; Zhang X; Liu J; Estrem S; Li S; Gong XQ; Buchanan S; Henry JR; Starling JJ; Peng SB
    J Biol Chem; 2012 Aug; 287(33):28087-98. PubMed ID: 22730329
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors.
    Oberholzer PA; Kee D; Dziunycz P; Sucker A; Kamsukom N; Jones R; Roden C; Chalk CJ; Ardlie K; Palescandolo E; Piris A; MacConaill LE; Robert C; Hofbauer GF; McArthur GA; Schadendorf D; Garraway LA
    J Clin Oncol; 2012 Jan; 30(3):316-21. PubMed ID: 22067401
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Positive and negative modulation of nicotinic receptors.
    Arias HR
    Adv Protein Chem Struct Biol; 2010; 80():153-203. PubMed ID: 21109220
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Extensive segmental acanthosis nigricans form of epidermal nevus.
    de Waal AC; van Rossum MM; Bovenschen HJ
    Dermatol Online J; 2010 Jun; 16(6):7. PubMed ID: 20579462
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of ARHGEF17, DENND2D, fgfr3, and RB1 mutations in melanoma by inhibition of nonsense-mediated mRNA decay.
    Bloethner S; Mould A; Stark M; Hayward NK
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1076-85. PubMed ID: 18677770
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. treatment of refractory chronic GVHD with rituximab: a GITMO study.
    Zaja F; Bacigalupo A; Patriarca F; Stanzani M; Van Lint MT; Filì C; Scimè R; Milone G; Falda M; Vener C; Laszlo D; Alessandrino PE; Narni F; Sica S; Olivieri A; Sperotto A; Bosi A; Bonifazi F; Fanin R;
    Bone Marrow Transplant; 2007 Aug; 40(3):273-7. PubMed ID: 17549053
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.